Loading...
•
Mar 31, 2021
Ashland Q2 2021 Earnings Report
Ashland's financial results reflected strategy execution, continued cost reduction, and improving industrial demand, but were negatively impacted by weather-related events and changing consumer habits.
Key Takeaways
Ashland reported sales of $598 million, a decrease of 2% compared to the prior-year period. Net income was $41 million, and adjusted EBITDA was $134 million, down from $142 million in the prior-year quarter. The company faced challenges from weather-related events in the U.S. Gulf Coast and changing consumer behavior due to the global pandemic.
Sales were $598 million, down 2% year-over-year.
Net income was $41 million, compared to a net loss of $582 million in the prior-year quarter.
Adjusted income from continuing operations was $64 million, compared to $69 million in the prior-year quarter.
Adjusted EBITDA was $134 million, down from $142 million in the prior-year quarter.
Ashland
Ashland
Ashland Revenue by Segment
Revenue by Segment
Life Sciences Revenue
CapyFin.comPersonal Care Revenue
CapyFin.comSpecialty Additives Revenue
CapyFin.comIntermediates Revenue
CapyFin.com Forward Guidance
For the full fiscal year, Ashland expects to recover a portion of the lost cost absorption as the impacted plants work to make up for some of the lost production during the quarter. Overall, our expectations for Ashland’s full year results have not changed.
Revenue & Expenses
Visualization of income flow from segment revenue to net income